Boston scientific receives fda approval for the vercise genus™ deep brain stimulation system

Marlborough, mass., jan. 22, 2021 /prnewswire/ -- boston scientific corporation (nyse: bsx) has received u.s. food and drug administration (fda) approval of its fourth-generation vercise genus™ deep brain stimulation (dbs) system. the portfolio, approved for conditional use in a magnetic...
BSX Ratings Summary
BSX Quant Ranking